Primary Site >> Liver Cancer
Gene >> STARD13
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. PMID: 12531887 |
Ref: Rho GTPase activating protein cDNA on chromosome 13q12 is the deleted in liver cancer (DLC2) gene. PMID: 14985079 |
Ref: Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. PMID: 16217026 |
Ref: Mitochondrial targeting of growth suppressor protein DLC2 through the START domain. PMID: 16364308 |
Ref: Solution structures, dynamics, and lipid-binding of the sterile alpha-motif domain of the deleted in liver cancer 2. PMID: 17380510 |
Ref: Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. PMID: 18651974 |
Ref: Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis. PMID: 19668331 |
Ref: Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1-ERK1/2-p70S6K signalling pathway. PMID: 20629949 |
Ref: DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma. PMID: 22614672 |
Ref: The STAR of the DLC family. PMID: 23316797 |
Ref: Effect of StarD13 on colorectal cancer proliferation, motility and invasion. PMID: 24253896 |
Ref: STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas. PMID: 27844181 |
Ref: STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells. PMID: 30214243 |